Obstructive suburethral mass after transurethral injection of dextranomer/hyaluronic acid copolymer.
Dextranomer/hyaluronic acid copolymer (Zuidex(R)) is a new bulking agent. There is little data about the complications of using this substance as urethral bulking agent for the treatment of urinary stress incontinence. We are presenting a 59-year-old female patient who developed a suburethral mass and urinary retention after zuidex urethral injection. A stepwise approach for treatment was followed. Complete excision of the mass was the only curative procedure that succeeded.
Abdelwahab
Hassan A
HA
Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd., Weston, FL 33331, USA.
Ghoniem
Gamal M
GM
D003911:Dextrans / Q000008:administration & dosage* / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage* / Q000009:adverse effects*; D007267:Injections; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D014521:Urethra / Q000601:surgery*; D014550:Urinary Incontinence, Stress / Q000473:pathology* / Q000601:surgery*
D003911:Dextrans; C013471:dextranomer; D006820:Hyaluronic Acid